Lv1
20 积分 2024-08-01 加入
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations
1天前
已完结
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis
1天前
已完结
106P Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Updated results from a pooled analysis of two phase I studies
4个月前
已关闭
Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
4个月前
已完结
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
4个月前
已完结
A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable colorectal cancer
4个月前
已关闭
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
4个月前
已完结
Efficacy and safety of vactosertib and pembrolizumab combination in patients with previously treated microsatellite stable metastatic colorectal cancer
4个月前
已关闭
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer
5个月前
已完结
Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy
5个月前
已完结
皖公网安备34019202002308
